CaveoVasc System - a New Femoral Vascular Access and Closure Device
Prospective, Single Arm Study to Assess the Performance and Safety of CaveoVasc System for Femoral Vascular Access and Closure Device
Sponsor: CaveoMed GmbH
Terminated
This trial was terminated. No reason was provided.
This NA trial investigates Catheterization Via a Femoral Sheath ≤ 6Fr and is currently terminated or withdrawn. CaveoMed GmbH leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Sep 2018 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Sep 2018 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Terminated NA
Status: Not Yet Recruiting → Terminated
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CaveoMed GmbH
- MedPass International
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.